Wasserstein Debt Opportunities Management’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$143M Sell
3,964,893
-608,470
-13% -$20.5M 54.09% 1
2026
Q1
$164M Sell
4,573,363
-1,000,035
-18% -$25.9M 86.96% 1
2025
Q4
$111M Sell
5,573,398
-243,614
-4% -$4.69M 100% 1
2025
Q3
$106M Hold
5,817,012
100% 1
2025
Q2
$91.6M Buy
5,817,012
+180,197
+3% +$2.29M 100% 1
2025
Q1
$71.5M Sell
5,636,815
-53,169
-0.9% -$835K 100% 1
2024
Q4
$125M Sell
5,689,984
-1,252,103
-18% -$26.3M 100% 1
2024
Q3
$124M Buy
6,942,087
+50,773
+0.7% +$814K 100% 1
2024
Q2
$111M Buy
6,891,314
+193,063
+3% +$3.05M 100% 1
2024
Q1
$99.5M Hold
6,698,251
100% 1
2023
Q4
$120M Buy
+6,698,251
New +$109M 100% 1

Other funds holding CLMT

Wasserstein Debt Opportunities Management's CLMT Position: Q2 2026 in Review

Wasserstein Debt Opportunities Management reduced its Calumet Specialty Products (CLMT) stake by 13% in Q2 2026, selling an estimated $20.5M and leaving 3,964,893 shares worth $143M. The position accounts for 54.09% of the portfolio, ranked #1.

Wasserstein Debt Opportunities Management first reported a position in CLMT in Q4 2023 and has held it in 11 quarters since. The position peaked at $164M in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Wasserstein Debt Opportunities Management held 3,964,893 shares of Calumet Specialty Products worth $143M as of Q2 2026.
  • Wasserstein Debt Opportunities Management sold 608,470 Calumet Specialty Products shares in Q2 2026, an estimated $20.5M.
  • Calumet Specialty Products made up 54.09% of Wasserstein Debt Opportunities Management's portfolio in Q2 2026, its #1 holding.
  • Wasserstein Debt Opportunities Management first reported a position in Calumet Specialty Products in Q4 2023 and has held it in 11 quarters since.
  • Wasserstein Debt Opportunities Management's Calumet Specialty Products position peaked at $164M in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Wasserstein Debt Opportunities Management's 13F filing for Q2 2026, filed 14 Aug 2026.